Holen Sie sich die Stockscreener-App
5.83
0.17%
-0.010
Handel nachbörslich:
5.80
-0.03
-0.51%
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World
Research Analysts Offer Predictions for OBIO FY2024 Earnings - Defense World
Orchestra BioMed (NASDAQ:OBIO) Earns "Buy" Rating from HC Wainwright - MarketBeat
Chardan Capital Reaffirms Buy Rating for Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully - Yahoo Finance
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs - MSN
Orchestra Biomed Reports Q3 2024 Financial Results - TipRanks
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire
Orchestra BioMed Q3 Revenue Jumps 150%, Extends Cash Runway Despite Wider Losses | OBIO Stock News - StockTitan
Orchestra BioMed to Present at Jefferies London Healthcare Conference - MyChesCo
Trading (OBIO) With Integrated Risk Controls - Stock Traders Daily
Orchestra BioMed to Participate in Jefferies London Healthcare Conference - GlobeNewswire
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) market cap surged US$23m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
HC Wainwright & Co. Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - MSN
Orchestra BioMed Appoints John Mack to Board of Directors - MSN
SkyView Investment Advisors LLC Invests $163,000 in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Rhumbline Advisers Buys 17,405 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 2,500 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - Defense World
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com Australia
Orchestra BioMed executive acquires shares worth over $47k - Investing.com India
Market Update: Ocular Therapeutix Inc (OCUL) Sees Negative Movement, Closing at 8.46 - The Dwinnex
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Bank of New York Mellon Corp - Defense World
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Logos Global Management LP - MarketBeat
Elevai Labs shares tumble on pricing of new stock offering - Sacramento Business Journal
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
L’Oreal partners with Evonik and Abolis to scale development of next-gen ingredients - GlobalCosmeticsNews
Video: A WONDERFUL WORLD Parades to Studio 54 - BroadwayWorld
The Cure 'Songs of a Lost World' billboard appears in NYC - Brooklyn Vegan
Exicure Shares More Than Double After Nasdaq Listing Extension - MarketWatch
Oxford Biomedica Emerges as OXB with Global Vision - TipRanks
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of European Wax Center, Inc.EWCZ - PR Newswire
Ocular Therapeutix Inc’s Market Journey: Closing Weak at 8.93, Down -0.78 - The Dwinnex
(OBIO) On The My Stocks Page - Stock Traders Daily
IPO NewsUP IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Renaissance Capital
L'Oreal, Evonik join $38.6 million funding round for biotech start-up Abolis - Fashion Network
Interactive Bible Study Course Demonstrated to Over 200 Individuals at International Fair in Angola - JW News
Orchestra BioMed executive sells over $73k in company stock - Investing.com India
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Director Eric S. Fain Sells 2,000 Shares of Stock - MarketBeat
Orchestra BioMed director sells over $30k in company shares - Investing.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells $41,705.70 in Stock - Defense World
Have Orchestra BioMed Holdings Insiders Been Selling Stock? - Simply Wall St
Orchestra BioMed executive sells over $120k in company stock - Investing.com India
Insider Selling: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells 6,819 Shares of Stock - MarketBeat
Orchestra BioMed executive sells over $120k in company stock By Investing.com - Investing.com UK
Orchestra BioMed Initiates BackBeat Pivotal Study Of AVIM Therapy - MPO-mag
Orchestra BioMed (NASDAQ:OBIO) Receives New Coverage from Analysts at HC Wainwright - MarketBeat
Orchestra BioMed shares initiated with Buy by H.C. Wainwright - Investing.com
HC Wainwright Begins Coverage on Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates - MSN
David P. Hochman Acquires 2,500 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock - Defense World
Chardan Capital Comments on Orchestra BioMed Holdings, Inc.’s FY2024 Earnings (NASDAQ:OBIO) - Defense World
Research Analysts Set Expectations for Orchestra BioMed Holdings, Inc.'s FY2024 Earnings (NASDAQ:OBIO) - MarketBeat
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):